Revision 4 for 'iRANO criteria'

All Revisions - View changeset

iRANO criteria

The immunotherapy response assessment for neuro-oncology (iRANO) criteria have been developed as a modification of RANO criteria to address the challenges of emerging novel immunotherapy for high-grade gliomas 1. Although these criteria have been primarily for the purposes of standardizing assessment of treatment response in the setting of clinical trials, they offer important guiding principles for everyday reporting. 

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.